China, Oct. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Effectiveness of A Culturally Adapted Social Skills Group Program: A Conceptual Surv... Read More
China, Oct. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Development and Empirical Study of a New Model for Community-Based Management of Lumbar ... Read More
China, Oct. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Study on the Establishment of Nutritional Metabolism Maps and Regulatory Mechanisms in S... Read More
China, Oct. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Isolation of Clinical Hypervirulent Multidrug-Resistant Bacterial Strains and Constructi... Read More
China, Oct. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Prospective Cohort Study on Predicting the Risk of Severe Inhalation Pneumonia and Its... Read More
China, Oct. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A phase II randomised controlled trial comparing carbon-ion radiotherapy (3 GyE in fract... Read More
China, Oct. 8 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'The Association Between Preoperative Bedside Signals and Neonatal Appendicitis and Necro... Read More
Singapore, Oct. 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 2 Platform Basket Study Evaluating Advanced Therapies in Subjects with Moderately to Severe... Read More
Singapore, Oct. 8 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Randomized, Open-Label Study of Rinzimetostat (ORIC-944) in Combination with Darolutamid... Read More
Singapore, Oct. 8 -- The Health Sciences Authority received information related to the study titled 'An Interventional Phase 3, Open Label, Randomized Study To Evaluate Efficacy And Safety of PF-08634... Read More